Article Text

Download PDFPDF
Maternal and child health
Antenatal magnesium sulfate treatment for women at risk of preterm birth is safe and might decrease the risk of cerebral palsy

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Contributors Invited commentary.

  • Funding This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests Both authors are primary investigators on an ongoing randomised controlled trial on the use of magnesium sulfate in preterm birth.

  • Patient consent Detail has been removed from this case description/these case descriptions to ensure anonymity. The editors and reviewers have seen the detailed information available and are satisfied that the information backs up the case the authors are making.

  • Provenance and peer review Commissioned; internally peer reviewed.

  • Collaborators Hanne Trap Wolf

  • Correction notice This article has been corrected since original publication to include a second author who was previously missed.